Literature DB >> 21701901

Murine gamma herpes virus 68 infection promotes fatty liver formation and hepatic insulin resistance in C57BL/6J mice.

Lei Zhao1, Ya-Xi Chen1, Zac Varghese2, Ai-Long Huang1, Ren-Kuan Tang1, Bei Jia1, John F Moorhead2, Jian-Ping Gong1, Xiong Z Ruan3,4.   

Abstract

PURPOSE: Murine gamma herpes virus 68 (MHV68) is a naturally occurring mouse pathogen that is homologous to Epstein-Barr virus. This study was designed to determine the correlation between MHV68 infection and lipid accumulation and insulin resistance in livers of C57BL/6J mice, and to explore the underlying mechanisms.
METHODS: C57BL/6J mice fed a high fat diet were randomly assigned to receive either MHV68 or phosphate buffered saline treatment. Insulin sensitivities were evaluated by glucose tolerance tests. Serum was analyzed for lipids and cytokines. Liver was taken for histology and lipid analysis. Quantitative RT-PCR and western blotting were used to measure expression of hepatic mammalian target of rapamycin (mTOR), ribosomal S6 kinase 1 (S6K1), insulin receptor substrate-1 (IRS-1), sterol regulatory element binding protein-1 (SREBP1), fatty acid synthase (FAS), and acetyl CoA carboxylase (ACC).
RESULTS: MHV68 infection promoted fatty liver, hypertriglyceridemia, insulin resistance, and hyperinsulinemia in association with elevated inflammatory cytokines. In the livers of MHV68-infected C57BL/6J mice, SREBP1, FAS, ACC levels were increased. MHV68 infection also inhibited total IRS-1 expression and increased serine phosphorylation levels of IRS-1, which is parallel to the over activation of mTOR signaling pathway. Sirolimus, a specific inhibitor of mTOR pathway, inhibited MHV68-induced hepatic expression of serine p-IRS-1, increased total IRS-1 levels and improved MHV68-induced hepatic insulin resistance.
CONCLUSION: In C57BL/6J mice, MHV68 infection promotes fatty liver formation and hepatic insulin resistance, which can be ameliorated by sirolimus.

Entities:  

Keywords:  Dyslipidemia; Infectious disease; Inflammation; Mammalian target of rapamycin; Nonalcoholic fatty liver disease

Year:  2011        PMID: 21701901     DOI: 10.1007/s12072-011-9283-x

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  27 in total

1.  Activation of mammalian target of rapamycin (mTOR) by insulin is associated with stimulation of 4EBP1 binding to dimeric mTOR complex 1.

Authors:  Lifu Wang; Christopher J Rhodes; John C Lawrence
Journal:  J Biol Chem       Date:  2006-06-23       Impact factor: 5.157

2.  Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells.

Authors:  F Tremblay; A Marette
Journal:  J Biol Chem       Date:  2001-08-09       Impact factor: 5.157

3.  Sertoli cell expression of steroidogenic acute regulatory protein-related lipid transfer 1 and 5 domain-containing proteins and sterol regulatory element binding protein-1 are interleukin-1beta regulated by activation of c-Jun N-terminal kinase and cyclooxygenase-2 and cytokine induction.

Authors:  Tomomoto Ishikawa; Keumsil Hwang; Deborah Lazzarino; Patricia L Morris
Journal:  Endocrinology       Date:  2005-08-25       Impact factor: 4.736

4.  Inflammatory liver steatosis caused by IL-12 and IL-18.

Authors:  Masaya Kaneda; Shin-Ichiro Kashiwamura; Haruyasu Ueda; Koji Sawada; Ayako Sugihara; Nobuyuki Terada; Akiko Kimura-Shimmyo; Yoshihiro Fukuda; Takashi Shimoyama; Haruki Okamura
Journal:  J Interferon Cytokine Res       Date:  2003-03       Impact factor: 2.607

5.  Rapamycin partially prevents insulin resistance induced by chronic insulin treatment.

Authors:  Cathleen E Berg; Brian E Lavan; Cristina M Rondinone
Journal:  Biochem Biophys Res Commun       Date:  2002-05-10       Impact factor: 3.575

6.  Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk.

Authors:  Gaby Kressel; Birgit Trunz; Achim Bub; Olaf Hülsmann; Maike Wolters; Ralf Lichtinghagen; Dirk O Stichtenoth; Andreas Hahn
Journal:  Atherosclerosis       Date:  2008-04-20       Impact factor: 5.162

7.  Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.

Authors:  Seung Ha Park; Byung Ik Kim; Jung Won Yun; Jeong Wook Kim; Dong Il Park; Yong Kyun Cho; In Kyung Sung; Chang Young Park; Chong Il Sohn; Woo Kyu Jeon; Hyang Kim; Eun Jung Rhee; Won Young Lee; Sun Woo Kim
Journal:  J Gastroenterol Hepatol       Date:  2004-06       Impact factor: 4.029

8.  Activation of mammalian target of rapamycin complex 1 and insulin resistance induced by palmitate in hepatocytes.

Authors:  Sylvie Mordier; Patrick B Iynedjian
Journal:  Biochem Biophys Res Commun       Date:  2007-08-09       Impact factor: 3.575

9.  Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice.

Authors:  Kun L Ma; Xiong Z Ruan; Stephen H Powis; Yaxi Chen; John F Moorhead; Zac Varghese
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

10.  Beta-Cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreas endocrine axis through insulin receptor A isoform.

Authors:  Oscar Escribano; Carlos Guillén; Carmen Nevado; Almudena Gómez-Hernández; C Ronald Kahn; Manuel Benito
Journal:  Diabetes       Date:  2009-01-09       Impact factor: 9.461

View more
  1 in total

1.  Predictive Value of Triglyceride-Glucose Index for In-hospital Mortality in Patients With Severe Fever With Thrombocytopenia Syndrome: A Multi-Center Observational Study.

Authors:  Tingyu Zhang; Yuanni Liu; Ziruo Ge; Di Tian; Ling Lin; Zhenghua Zhao; Yi Shen; Xiaoli Yu; Yang Feng; Chunqian Qiang; Jianping Duan; Yanli Ma; Tianli Fan; Yongxiang Zhao; Zhihai Chen
Journal:  Front Med (Lausanne)       Date:  2022-01-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.